These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
632 related articles for article (PubMed ID: 12604886)
1. CDX2, a highly sensitive and specific marker of adenocarcinomas of intestinal origin: an immunohistochemical survey of 476 primary and metastatic carcinomas. Werling RW; Yaziji H; Bacchi CE; Gown AM Am J Surg Pathol; 2003 Mar; 27(3):303-10. PubMed ID: 12604886 [TBL] [Abstract][Full Text] [Related]
2. The homeobox intestinal differentiation factor CDX2 is selectively expressed in gastrointestinal adenocarcinomas. Kaimaktchiev V; Terracciano L; Tornillo L; Spichtin H; Stoios D; Bundi M; Korcheva V; Mirlacher M; Loda M; Sauter G; Corless CL Mod Pathol; 2004 Nov; 17(11):1392-9. PubMed ID: 15205684 [TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical staining in the diagnosis of pancreatobiliary and ampulla of Vater adenocarcinoma: application of CDX2, CK17, MUC1, and MUC2. Chu PG; Schwarz RE; Lau SK; Yen Y; Weiss LM Am J Surg Pathol; 2005 Mar; 29(3):359-67. PubMed ID: 15725805 [TBL] [Abstract][Full Text] [Related]
4. CDX2 immunostaining as a gastrointestinal marker: expression in lung carcinomas is a potential pitfall. Mazziotta RM; Borczuk AC; Powell CA; Mansukhani M Appl Immunohistochem Mol Morphol; 2005 Mar; 13(1):55-60. PubMed ID: 15722794 [TBL] [Abstract][Full Text] [Related]
5. CDX-2 homeobox gene expression is a reliable marker of colorectal adenocarcinoma metastases to the lungs. Barbareschi M; Murer B; Colby TV; Chilosi M; Macri E; Loda M; Doglioni C Am J Surg Pathol; 2003 Feb; 27(2):141-9. PubMed ID: 12548159 [TBL] [Abstract][Full Text] [Related]
6. Tissue-specific cadherin CDH17 is a useful marker of gastrointestinal adenocarcinomas with higher sensitivity than CDX2. Panarelli NC; Yantiss RK; Yeh MM; Liu Y; Chen YT Am J Clin Pathol; 2012 Aug; 138(2):211-22. PubMed ID: 22904132 [TBL] [Abstract][Full Text] [Related]
7. The value of CDX2 and cytokeratins 7 and 20 expression in differentiating colorectal adenocarcinomas from extraintestinal gastrointestinal adenocarcinomas: cytokeratin 7-/20+ phenotype is more specific than CDX2 antibody. Bayrak R; Haltas H; Yenidunya S Diagn Pathol; 2012 Jan; 7():9. PubMed ID: 22268990 [TBL] [Abstract][Full Text] [Related]
8. CDX2 may be a useful marker to distinguish primary ovarian carcinoid from gastrointestinal metastatic carcinoids to the ovary. Desouki MM; Lioyd J; Xu H; Cao D; Barner R; Zhao C Hum Pathol; 2013 Nov; 44(11):2536-41. PubMed ID: 24029704 [TBL] [Abstract][Full Text] [Related]
9. CDX2 is a useful marker of intestinal-type differentiation: a tissue microarray-based study of 629 tumors from various sites. De Lott LB; Morrison C; Suster S; Cohn DE; Frankel WL Arch Pathol Lab Med; 2005 Sep; 129(9):1100-5. PubMed ID: 16119980 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of CDX2 in primary ovarian mucinous tumors and metastatic mucinous carcinomas involving the ovary: comparison with CK20 and correlation with coordinate expression of CK7. Vang R; Gown AM; Wu LS; Barry TS; Wheeler DT; Yemelyanova A; Seidman JD; Ronnett BM Mod Pathol; 2006 Nov; 19(11):1421-8. PubMed ID: 16980943 [TBL] [Abstract][Full Text] [Related]
11. CDX-2, a new marker for adenocarcinoma of gastrointestinal origin. Li MK; Folpe AL Adv Anat Pathol; 2004 Mar; 11(2):101-5. PubMed ID: 15090846 [TBL] [Abstract][Full Text] [Related]
12. Value of CDX2, villin, and alpha-methylacyl coenzyme A racemase immunostains in the distinction between primary adenocarcinoma of the bladder and secondary colorectal adenocarcinoma. Suh N; Yang XJ; Tretiakova MS; Humphrey PA; Wang HL Mod Pathol; 2005 Sep; 18(9):1217-22. PubMed ID: 15803184 [TBL] [Abstract][Full Text] [Related]
13. The value of Cdx2 immunostaining in differentiating primary ovarian carcinomas from colonic carcinomas metastatic to the ovaries. Groisman GM; Meir A; Sabo E Int J Gynecol Pathol; 2004 Jan; 23(1):52-7. PubMed ID: 14668551 [TBL] [Abstract][Full Text] [Related]
14. Immunohistochemistry in the Diagnosis of Mucinous Neoplasms Involving the Ovary: The Added Value of SATB2 and Biomarker Discovery Through Protein Expression Database Mining. Strickland S; Wasserman JK; Giassi A; Djordjevic B; Parra-Herran C Int J Gynecol Pathol; 2016 May; 35(3):191-208. PubMed ID: 26535987 [TBL] [Abstract][Full Text] [Related]
15. Use of novel immunohistochemical markers expressed in colonic adenocarcinoma to distinguish primary ovarian tumors from metastatic colorectal carcinoma. Logani S; Oliva E; Arnell PM; Amin MB; Young RH Mod Pathol; 2005 Jan; 18(1):19-25. PubMed ID: 15389251 [TBL] [Abstract][Full Text] [Related]
16. Expression of the intestinal marker Cdx2 in secondary adenocarcinomas of the colorectum. Groisman GM; Bernheim J; Halpern M; Brazowsky E; Meir A Arch Pathol Lab Med; 2005 Jul; 129(7):920-3. PubMed ID: 15974817 [TBL] [Abstract][Full Text] [Related]
17. LEF-1 is frequently expressed in colorectal carcinoma and not in other gastrointestinal tract adenocarcinomas: an immunohistochemical survey of 602 gastrointestinal tract neoplasms. Kermanshahi TR; Jayachandran P; Chang DT; Pai R Appl Immunohistochem Mol Morphol; 2014; 22(10):728-34. PubMed ID: 25394300 [TBL] [Abstract][Full Text] [Related]
18. Utility of tissue-specific transcription factors thyroid transcription factor 1 and Cdx2 in determining the primary site of metastatic adenocarcinomas to the brain. Strickland-Marmol LB; Khoor A; Livingston SK; Rojiani A Arch Pathol Lab Med; 2007 Nov; 131(11):1686-90. PubMed ID: 17979487 [TBL] [Abstract][Full Text] [Related]
19. Distribution and pattern of expression of villin, a gastrointestinal-associated cytoskeletal protein, in human carcinomas: a study employing paraffin-embedded tissue. Bacchi CE; Gown AM Lab Invest; 1991 Mar; 64(3):418-24. PubMed ID: 2002658 [TBL] [Abstract][Full Text] [Related]
20. Expression of the intestinal transcription factor CDX2 in carcinoid tumors is a marker of midgut origin. Jaffee IM; Rahmani M; Singhal MG; Younes M Arch Pathol Lab Med; 2006 Oct; 130(10):1522-6. PubMed ID: 17090195 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]